These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 8734135)

  • 1. [Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices].
    Pucheu A; Leduc B; Sillet-Bach I; Payen C; Assaf W; Pucheu M
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):59-63. PubMed ID: 8734135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis].
    Pucheu A; Dierhas M; Leduc B; Sillet-Bach I; Lefort S; Assaf W; Pucheu M
    Bull Cancer; 1996 Apr; 83(4):293-9. PubMed ID: 8680080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep vein thrombosis].
    Moreno-Palomares JJ; Fisac-Herrero RM; Herrero-Domingo A; Ferreira-Pasos EM; Grasa J; Reverte-Cejudo D
    An Med Interna; 2001 Jul; 18(7):364-8. PubMed ID: 11534421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
    Naz R; Naz S; Mehboob M; Khalid GH
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H
    Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.
    ; Buller H; Deitchman D; Prins M; Segers A
    J Thromb Haemost; 2008 Aug; 6(8):1313-8. PubMed ID: 18541000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma.
    Ginzburg E; Cohn SM; Lopez J; Jackowski J; Brown M; Hameed SM;
    Br J Surg; 2003 Nov; 90(11):1338-44. PubMed ID: 14598411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
    Moreno Gonzalez E; Fontcuberta J; de la Llama F
    Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
    Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
    Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial.
    Prandoni P; Tormene D; Pesavento R;
    J Thromb Haemost; 2005 Jun; 3(6):1152-7. PubMed ID: 15946202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implantable devices for permanent venous access. A single-center prospective study comparing an AIDS population with a control population (80 cases)].
    Johanet H; Saliou C; Marmuse JP; Benhamou G; Charleux H
    Ann Chir; 1991; 45(6):497-501. PubMed ID: 1929166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.